Kathleen Tregoning
Director/Board Member at SPERO THERAPEUTICS, INC.
Net worth: 470 169 $ as of 29/04/2024
Kathleen Tregoning active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Public Communications Contact | 30/06/2020 | - |
| SPERO THERAPEUTICS, INC. | Director/Board Member | 10/10/2021 | - |
| Independent Dir/Board Member | 10/10/2021 | - |
Career history of Kathleen Tregoning
Former positions of Kathleen Tregoning
| Companies | Position | Start | End |
|---|---|---|---|
| SANOFI | Public Communications Contact | 31/01/2017 | 29/02/2020 |
Biogen France SAS
 Biogen France SAS BiotechnologyHealth Technology Biogen France SAS engages in research and development of biotechnology. The company was founded in 1994 and is headquartered in Paris, France. | Corporate Officer/Principal | 31/12/2005 | - |
Training of Kathleen Tregoning
| Stanford University | Undergraduate Degree |
| Harvard Kennedy School of Government | Graduate Degree |
Statistics
International
| United States | 5 |
| France | 3 |
Operational
| Public Communications Contact | 2 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| SANOFI | Health Technology |
| SPERO THERAPEUTICS, INC. | Health Technology |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Biogen France SAS
Biogen France SAS BiotechnologyHealth Technology Biogen France SAS engages in research and development of biotechnology. The company was founded in 1994 and is headquartered in Paris, France. | Health Technology |
- Stock Market
- Insiders
- Kathleen Tregoning
- Experience
